Embed Size (px)
Citation preview
Part-financed by the European Union (European Regional Development Fund)
Masterplan Marine Biotechnology Schleswig-Holstein
A Regional Development Strategy
Imke Schneemann
29. August 2012
Concarneau
Life Science Nord
Norgenta
Cluster “Life Science Nord”
MedTech, Pharma, Biotech
Clustermanagment agency: Norgenta
Foundet in 2004 by the Free and Hanseatic City of Hamburg and
the state Schleswig-Holstein
2010: Involvement of industry through public-private-partnership
Mission: growth and employment within the Clusters
500 companies in MedTec, Pharma and Biotech
2 university medical centers, 5 unis, 12 research institutes, 14 technology parks
Clusters of excellence: Inflammation at Interfaces & Future Ocean
Focus topics within Biotech:
Drug research, molecular diagnostics, cell technologies and marine biotechnology
CSA MarineBiotech & SUBMARINER
The Project
SUBMARINER – Sustainable Uses of Baltic Marine Resource
Baltic Sea Region Program (2007-2013)
Total project budget: 3,6 Mio €
Time of project: Oct. 2010 - Dec. 2013
19 partners from 8 BSR countries
Lead Partner: Maritime Institute in Gdańsk
Coordinator: s.Pro (Berlin)
Activities
Compendium – Describing current and potential future marine uses
Comprehensive inventory of current and new uses
Strengths, weaknesses, opportunities and threats
Economic and ecological impact assessment
State and availability of technologies
Market potential
Gaps and obstacles in legal framework
Regional pilot studies– Testing new uses in real conditions
Feasibility studies for new uses
Technological and financial needs
Impact on environmental and socioeconomic conditions
Specific legal constrains
Activities
Regional development stratgies
BSR Raodmap – Recommending necessary policy steps to promote beneficial uses
and mitigate against negative impacts
Legal changes
Environmental regulations
Economic incentives
BSR Network – Bringing relevant players together
Business cooperation events
Network structure
Virtual information and exchange platform
Regional, national and BSR-wide roundtables and seminars on new marine uses
SUBMARINER Flagship application
Schleswig-Holstein
Schleswig-Holstein
Total Area: 15.799 km2
Capital: Kiel (240.000)
Population: 2,83 Mio
Economically active population: 1,28 Mio
Rate of unemployment: 7% (national average 7,2%)
Business: 99% are SMEs (less than 250 employees)
Focus: Medical technic, maritime, food, information and communication technology,
machinery, renewable energy, health, life science
Life Science: medicine, medtech, biotech, pharmacy
Masterplan Marine Biotechnology
Schleswig-Holstein
Time schedule
Oct 2010 Dec 2013 Development Masterplan
Norgenta & dsn
Nov 2011 Nov 2012 Online survey
Interviews
Additional discussions
Workshops Advisory board meetings
Model for other regions
Masterplan Marine Biotechnology
Schleswig-Holstein
Establishment of an advisory board consisting of representatives from economic
(big company: DuPont & SME: CRM), politic (federal: BMWi & regional: MWV),
partner cluster organization (BioCon Valley), science (director GEOMAR, director
EMB)
4 advisory board meetings
Advisory board
Contractor
dsn
Client
Norgenta
Community
Masterplan Marine Biotechnology
Schleswig-Holstein
objective
„The Masterplan should provide a clear roadmap to a strategic development of marine
biotechnology in Schleswig-Holstein. Promising potentials should be used in the
interest of sustainability by systematically transfer of technology and know-how as well
as in terms of growth and employment.”
Masterplan Marine Biotechnology
Schleswig-Holstein
Nov 2011 - Nov 2012
Advisory board
Definition of marine biotech uses and users
Status analysis of companies, research institutions and further stakeholders
Determination of trends, needs and potential uses
Highlight strengths, weaknesses, opportunities and threats
Recommendations and proposals for projects
Module 7
Final presentation
Masterplan Marine Biotechnology
Schleswig-Holstein
Modules for development
Module 2
Document
analysis and
processing of
information
Module 3
Online survey
Module 4
Structure
interviews and
additional
discussion
Module 5
Workshops
Database
Module 6
Preparation of the document “Masterplan”
Module
1
Pro
ject m
ana
gem
en
t
Module 7
Final presentation
Masterplan Marine Biotechnology
Schleswig-Holstein
Modules for development
Module 2
Analysis of
stakeholders;
development
of value
chains
Module 3
Online survey
44 business
22 research
Module 4
Structure
interviews and
additional
discussion
Module 5
1st Workshop
on SWOT
2nd Workshop
on activities
Establishment of a database
Module 6
Preparation of the document “Masterplan”
Module
1
Pro
ject m
ana
gem
en
t
Players in Schleswig-Holstein
Reseach
GEOMAR Helmholtz Centre for Ocean Research Kiel
www.geomar.de
Kieler Wirkstoff-Zentrum: Biological active substances from marine microorganisms for
application in the field of human and animal health, plant protection, cosmetics and
neutraceuticals
Fraunhofer Research Institution for Marine Biotechnology
www.emb.fraunhofer.de/en
Aquatic cell culture and aquaculture
Business
Sea & Sun Technology GmbH
www.sea-sun-tech.com
Cultivation of microalgaes for different applications
Coastal Research & Management/oceanBASIS
www.crm-online.de/www.oceanbasis.de
Research in the field of biological active substances from marine macroorganisms. Production
of marine cosmetics.
Most Innovative
Natural Product 2012:
OceanCollagen Face
Cream
contacted questionnaire
completed
questionnaire
started
(50% & more)
only answered
questions on
value chain
Not active in
MB
rejection
Feedback in
total
questionnaire
business 44 13 3
2
6 4 18
questionnaire
science 22 12 0 - 1 0 12
Online survey
Status 08.08.2012
3
3
4
predominantly basic research
predominantly applied research
basic and applied research approx.equal
Research institution
orientation of activity
n=10
Research institution
scope of activities
0 2 4 6 8 10
energy
industrial processes, process…
food
diagnostics
cosmetics
environment
chemistry
aquaculture
pharmacy
n=11
multiple answers possible
Quality
location for research
0 2 4 6 8 10 12
International
National
n=11
very good
good
satisfactory
defective
pass
fail
Business
scope of activities
0 2 4 6 8 10
others
environment
energy
industrial processes, process…
chemistry
cosmetics
food
aquaculture
diagnostics
pharmacy
priority 1
priority 2
priority 3
n=16
multiple answers possible
Business
products & services on the market
n=16
8 8 yes
no
Business
location for business
n=11
0% 20% 40% 60% 80% 100%
national comparison
international comparison
very good
good
satisfactory
defective
pass
fail
Business
participation in funding programs
n=16
4
8
6 yes, EU funding programs
yes, German funding programs
no
SWOT
some examples
Strengths existing academic expertise (GEOMAR, EMB, cluster of excellence “Future Ocean”)
technological equipment
Weaknesses short-term funding
less cooperation between research and industry
scarcity of financial resources and stakeholders
Opportunities Increase use of renewable resources and alternative technologies
Partizipation in ERA-NET MB
Threats less risk-taking of investors
less focussing on „some“ topics
Proposed Activities
some suggestions from stakeholders
Research combination of technologically and ecologically approaches
Industrialization marine biotechnicum
Economy
food from marine resources
Qualification qualification of non-academic staff
study course “marine biotech”
Dialog & structure strengthening interaction
joint internet platform
awareness raising campaign in industry
Vision
Vision 1 Schleswig-Holstein – region of competence between the Seas! Marine Biotechnology as a
model for education, research and business.
Vision 2 In 10 years, Schleswig-Holstein will be the engine that ensures the quality of life through
marine biotechnology from healthy oceans
Vision 3 2030 Schleswig-Holstein will have the same value creation through marine biotechnology as
through conventional agriculture
Vision 4 Schleswig-Holstein will be an international leader for the development and implementation of
sustainable technologically solutions, which will contribute to
- resource-conserving use of the environment
- CO2-neutral energy supply
- human health
by using marine resources
